Erin Fowler
Nurse Practitioner · Santa Rosa Beach, FLNPI 1053639427
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.7% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,114 and has fallen 85.1% since, to $166 in 2025.
Across 66 payments — averaging $34.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$370
- GSK$289
- Myriad Genetic Laboratories, Inc.$155
- AbbVie$154
- Galderma Laboratories, L.p.$149
- AstraZeneca$140
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,11793%
- Education$1667%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 10 | $370 |
| GSK | 3 | $289 |
| Myriad Genetic Laboratories, Inc. | 3 | $155 |
| AbbVie | 6 | $154 |
| Galderma Laboratories, L.p. | 1 | $149 |
| AstraZeneca | 2 | $140 |
| Sanofi | 2 | $116 |
| E.r. Squibb & Sons, L.L.C. | 3 | $113 |
| Exelixis Inc. | 5 | $104 |
| Regeneron Healthcare Solutions, Inc. | 2 | $97 |
| Astellas Pharma US Inc | 1 | $67 |
| Blueprint Medicines Corporation | 3 | $62 |
| Johnson & Johnson | 3 | $52 |
| Bristol Myers Squibb | 3 | $51 |
| Pfizer | 2 | $38 |
| Novo Nordisk | 2 | $36 |
| Eisai Inc. | 2 | $35 |
| Rigel Pharmaceuticals, Inc. | 2 | $34 |
| Beigene USA, Inc. | 1 | $27 |
| Novartis | 1 | $24 |
| Progenics Pharmaceuticals, Inc. | 1 | $23 |
| Octapharma USA, Inc. | 1 | $23 |
| Merck | 1 | $20 |
| Clovis Oncology, Inc. | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| ADC Therapeutics America, Inc. | 1 | $17 |
| Myovant Sciences Inc. | 1 | $16 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,283 in reported general payments places this provider in the 85th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NitrofurantoinNitrofurantoin Macrocrystal | 15 | $258 |
| Ropinirole Hcl | 14 | $110 |
| Sertraline Hcl | 15 | $69 |
| Levothyroxine Sodium | 14 | $42 |
| Pantoprazole Sodium | 14 | $35 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Santa Rosa Beach
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.